| Literature DB >> 29212491 |
Naru Babaya1, Yukako Makutani1, Shinsuke Noso1, Yoshihisa Hiromine1, Hiroyuki Ito1, Yasunori Taketomo1, Kazuki Ueda2, Hokuto Ushijima2, Yoshifumi Komoike2, Yuto Yamazaki3, Hironobu Sasano3, Yumiko Kawabata1, Hiroshi Ikegami4.
Abstract
BACKGROUND: We report a rare case of a juxta-adrenal schwannoma that could not be discriminated from an adrenal tumor before surgical resection and was complicated by bilateral hyperaldosteronism. To the best of our knowledge, this is first case in which both a juxta-adrenal schwannoma and hyperaldosteronism co-existed. CASEEntities:
Keywords: Aldosterone-producing cell clusters; Hyperaldosteronism; Incidentaloma; Micronodular hyperplasia; Paradoxical hyperplasia
Mesh:
Year: 2017 PMID: 29212491 PMCID: PMC5719664 DOI: 10.1186/s12902-017-0225-z
Source DB: PubMed Journal: BMC Endocr Disord ISSN: 1472-6823 Impact factor: 2.763
Fig. 1CT of the left adrenal area showing a mass (4.5 × 3.8 cm) when the patient was 60 years old (a) and a larger mass (5.8 × 5.2 cm) when he was 69 years old (b). MRI of the left adrenal area on T1-WI (c) and T2-WI (d) when the patient was 69 years old. Yellow arrows show the lesions of the adrenal area
Laboratory data
| Peripheral blood | Endocrinological data | Load test | ||||||
| WBC | 5630/mm3 | (3300–8600) | [plasma] | [captopril] | ||||
| RBC | 410 × 104/mm3 | (435–555) | Epinephrine | < 5 pg/mL | (0–100) | Renin | 0 min | 0.3 ng/mL/h |
| Hb | 13.0 g/dL | (13.7–16.8) | Norepinephrine | 69 pg/mL | (100–450) | 60 min | < 0.1 ng/mL/h | |
| Ht | 38.9% | (40.7–50.1) | Dopamine | 13 pg/mL | (0–20) | 90 min | < 0.1 ng/mL/h | |
| Plt | 13.8 × 104/mm3 | (15.8–34.8) | Renin | 0.2 ng/mL/h | (0.3–2.9) | Aldosterone | 0 min | 84.7 pg/mL |
| Aldosterone | 66 pg/mL | (29.9–159) | 60 min | 77.1 pg/mL | ||||
| Biochemical data | ARR | 330 | (< 200) | 90 min | 72.7 pg/mL | |||
| T.P. | 6.6 g/dL | (6.6–8.1) | ACTH | 24.5 pg/mL | (7.2–63.3) | |||
| Alb | 4.2 g/dL | (4.1–5.1) | Cortisol | 11.1 μg/dL | (6.2–19.4) | [furosemide with upright position] | ||
| T.Bil | 0.8 mg/dL | (0.4–1.5) | DHEA-S | 100 μg/dL | (24–244) | Renin | 0 min | 0.3 ng/mL/h |
| AST | 18 U/L | (13–30) | 30 min | 0.5 ng/mL/h | ||||
| ALT | 15 U/L | (10–42) | [urine] | 60 min | 0.7 ng/mL/h | |||
| LDH | 207 U/L | (124–222) | Epinephrine | 5.5 μg/day | (3.4–26.9) | 120 min | 0.9 ng/mL/h | |
| ALP | 149 U/L | (106–322) | Norepinephrine | 97.9 μg/day | (48.6–168.4) | Aldosterone | 0 min | 70.1 pg/mL |
| rGTP | 20 U/L | (13–64) | Dopamine | 932.6 μg/day | (365–961.5) | 30 min | 154 pg/mL | |
| BUN | 16 mg/dL | (8–20) | Aldosterone | 4.7 μg/day | (0–10) | 60 min | 177 pg/mL | |
| Crea | 0.84 mg/dL | (0.65–1.07) | Cortisol | 45.3 μg/day | (11.2–80.3) | 120 min | 203 pg/mL | |
| Na | 140 mEq/L | (138–145) | ||||||
| K | 4.0 mEq/L | (3.6–4.8) | ||||||
| Cl | 108 mEq/L | (101–108) | ||||||
| Glu | 97 mg/dL | (73–109) | ||||||
| T.chol | 153 mg/dL | (142–220) | ||||||
| HbA1c | 5.8% | (4.9–6.2) | ||||||
Reference ranges are in parentheses. The judgment criteria of the load tests are as reported in [4]
Fig. 2Adrenal venous sampling with ACTH stimulation. The PAC and serum cortisol levels in venous samples were selectively collected with a catheter. PAC: plasma aldosterone concentration (pg/mL). F: cortisol (μg/dL). IVC: inferior vena cava. LAV: left adrenal vein. LRV: left renal vein. RAV: right adrenal vein. RRV: right renal vein
Fig. 3Macroscopic appearance (a) and photomicrograph (b-e) of the resected tumor. b The tumor was composed of a high cellular density area (Antoni A, yellow arrow) and low cellular density area (Antoni B, black arrow) (HE stain). c The Antoni A area included spindle-shaped cells with nuclear palisading (yellow arrow) (HE stain). d, e Immunohistochemical labeling in S-100. HE: Hematoxylin and eosin
Fig. 4Photomicrograph of the resected left adrenal gland. a Immunohistochemical labeling in CYP11B2. Although the zona glomerulosa was almost negative for CYP11B2, several nodules were strongly positive (black and yellow arrows). b, c The CYP11B2-positive nodule indicated by a black arrow in Fig. 4a was magnified. Immunohistochemical labeling in CYP11B2 (b) and in CYP11B1 (c) CYP11B2: cytochrome P450 family 11 subfamily B member 2, CYP11B1: cytochrome P450 family 11 subfamily B member 1